Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • Cataract surgery
High Glaucoma Risk in Pseudoexfoliation Syndrome: Age and Ocular Hypertension Drive Incidence
Posted innews Ophthalmology

High Glaucoma Risk in Pseudoexfoliation Syndrome: Age and Ocular Hypertension Drive Incidence

Posted by MedXY By MedXY 04/23/2026
New study reveals 26.5-37.5% of eyes with pseudoexfoliation syndrome develop glaucoma within 4 years, with ocular hypertension doubling risk. Standalone lens extraction reduced IOP by 3 mmHg.
Read More
LISA MRS Formula Outperforms Existing Standards for IOL Calculation in Post-Refractive Surgery Patients, Especially in High Myopia
Posted innews Ophthalmology

LISA MRS Formula Outperforms Existing Standards for IOL Calculation in Post-Refractive Surgery Patients, Especially in High Myopia

Posted by MedXY By MedXY 03/19/2026
A new IOL power calculation formula, LISA MRS, demonstrates superior accuracy for cataract patients with prior myopic refractive surgery, significantly outperforming existing formulas in eyes with axial lengths of 28 mm or greater by utilizing posterior corneal radius data.
Read More
Impact of Long-Term Intravitreal Anti-VEGF Injections on Cataract Progression and Surgical Outcomes
Posted innews Ophthalmology

Impact of Long-Term Intravitreal Anti-VEGF Injections on Cataract Progression and Surgical Outcomes

Posted by MedXY By MedXY 03/16/2026
A longitudinal study of 603 patients demonstrates that chronic intravitreal anti-VEGF therapy significantly accelerates cataract development, particularly posterior subcapsular opacities, resulting in an eightfold increased risk for cataract surgery compared to untreated fellow eyes.
Read More
Institutional Policy Shifts on Penicillin Allergy Labels Dramatically Increase Cefuroxime Use in Cataract Surgery
Posted inAllergy & Immunology news Ophthalmology

Institutional Policy Shifts on Penicillin Allergy Labels Dramatically Increase Cefuroxime Use in Cataract Surgery

Posted by MedXY By MedXY 03/13/2026
A large-scale quality improvement study reveals that reclassifying penicillin allergies and providing pharmacy support can increase the use of intracameral cefuroxime from 2% to over 70%, significantly improving evidence-based prophylaxis in cataract surgery.
Read More
Low-Level Light Therapy: A New Frontier in Preventing Dry Eye After Cataract Surgery
Posted inClinical Updates news Ophthalmology Specialties

Low-Level Light Therapy: A New Frontier in Preventing Dry Eye After Cataract Surgery

Posted by MedXY By MedXY 09/01/2025
Low-level light therapy, administered perioperatively, significantly reduces dry eye symptoms and preserves ocular surface integrity after cataract surgery, offering a noninvasive adjunct to standard care.
Read More
  • Antifungal Therapy Slashes Mortality in COVID-19-Associated Pulmonary Aspergillosis: European Data Confirms
  • Whole Genome Sequencing Outperforms Gene Panels in Diagnosing Congenital Cataracts
  • Personalized Glaucoma Coaching Boosts Medication Adherence by 20%: SEE Program Trial Results
  • High Glaucoma Risk in Pseudoexfoliation Syndrome: Age and Ocular Hypertension Drive Incidence
  • Post-Thyroidectomy Calcium Strategies: Routine vs. PTH-Guided Supplementation Show Similar Efficacy
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in